Condition: Migraine Disorders · Sponsor: Kafrelsheikh University
Investigators aim to compare the effect of valproate versus propranolol in migraine by assessing the absolute reduction in MMD in each group and the percentage of patients who achieved ≥ 50% reduction in the monthly headache days frequency compared to the baseline frequency.
This description comes directly from the study's public registry record.
mohamed G. Zeinhom, MD · 2001009606828 · mohamed_gomaa@med.kfs.edu.eg
sherihan R. ahmed, MD · 2001113432342 · sherihanrezk2016@gmail.com
Always discuss trial participation with your own doctor first.
| Kafr Elsheikh University Hospital | Kafr ash Shaykh, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06485726